Condition
Limited Stage Small Cell Lung Cancer clinical trials and research
Research outlook What's coming for Small cell lung cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 10 Limited Stage Small Cell Lung Cancer clinical trials that are recruiting, at sites in 11 countries (most in China (6), United States (2), Spain (2)). By phase: Phase 2 (5), Phase 3 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 11Countries
Newest Limited Stage Small Cell Lung Cancer clinical trials
All recruiting trials (10)
-
Shrinkage-free combo in LS-SCLC: SHR-7787 plus SHR-1316
This trial tests whether the combo of SHR-7787 and SHR-1316 can help adults with unresectable limited-stage small cell lung cancer after prior platinum-based chemo and radiation.
-
Trilaciclib to Protect the Blood System in Limited-Stage Small Cell Lung Cancer
This trial tests whether trilaciclib can protect blood-forming cells in people with limited-stage small cell lung cancer when given with standard therapy, compared with placebo.
-
Tarlatamab as maintenance treatment after chemo-radiotherapy for limited-stage small-cell lung cancer.
This trial will test whether giving tarlatamab after chemo-radiotherapy helps people with limited-stage small-cell lung cancer stay progression-free longer.
-
Durvalumab consolidation after chemoradiation for limited-stage small-cell lung cancer in China
This project will test durvalumab given after chemoradiation in people with limited‑stage small‑cell lung cancer who have not progressed, to see how well it works and how safe it is in routine care.
-
Probiotics plus intensified hyperfractionated chemoradiation with adebrelimab maintenance for limited-stage small cell lung cancer
This trial tests whether adding probiotics and an intensified hyperfractionated radiotherapy plan to chemo, followed by adebrelimab maintenance, helps people with limited-stage small cell lung cancer.
-
Combination therapy for limited-stage small cell lung cancer
This study is testing a new combination of immunotherapy and chemotherapy to see if it can help people with limited-stage small cell lung cancer have better treatment results.
-
Combination treatment for extensive stage small cell lung cancer
This study is testing a new combination treatment for people with extensive stage small cell lung cancer to see if it helps them live longer and feel better.
-
Using sugemalimab to treat limited stage small cell lung cancer after chemotherapy and radiotherapy
This study is testing if the drug sugemalimab can help people with limited stage small cell lung cancer stay cancer-free after they have completed chemotherapy and radiotherapy.
-
Comparing brain radiation to MRI monitoring in lung cancer patients after treatment
This study is testing whether giving brain radiation can help prevent lung cancer from spreading to the brain better than just keeping an eye on it with MRI scans in patients who are in remission.
-
Comparing brain MRI surveillance to prophylactic cranial irradiation in small cell lung cancer patients
This study is testing if regular brain MRIs alone can help small cell lung cancer patients just as much as a combination of brain MRIs and preventive radiation therapy.
Related topics
Quick answers
How many Limited Stage Small Cell Lung Cancer clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in China (6 trials), United States (2 trials), Spain (2 trials), Austria (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.